PROTEINA CO.,LTD. Logo

PROTEINA CO.,LTD.

A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.

468530 | KO

Overview

Corporate Details

ISIN(s):
KR7468530001
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로33길 11 구로동, 에이스테크노타워8차 13층 1301호, 구로구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PROTEINA CO., LTD. is a biotechnology company specializing in proteomics, focusing on the analysis of protein-protein interactions (PPI). Established in 2015, the company develops technologies to drive next-generation precision therapies and diagnostics. Its core innovation is the proprietary SPID (Single-molecule Protein Interaction Detection) platform, which enables real-time, high-resolution detection of protein interactions at the single-molecule level with unmatched sensitivity. PROTEINA's mission is to revolutionize protein analysis to facilitate the discovery of new drug candidates and the development of effective diagnostic approaches, particularly in oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.7 KB
2025-09-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 61.0 KB
2025-09-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 76.5 KB
2025-09-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 77.6 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 77.3 KB
2025-09-04 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 18.1 KB
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 66.0 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.0 KB
2025-08-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 146.2 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all PROTEINA CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROTEINA CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROTEINA CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America
AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America
AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America
AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America
TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America
ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America
ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America
ALGS
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark
ALK

Talk to a Data Expert

Have a question? We'll get back to you promptly.